🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Self-Management Data and Disease Progression in Chronic Kidney Disease

Recruitingn/aAges 19 Years - 84 YearsAllChungnam National University Hospital
NCT07754097 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study evaluates disease progression and management characteristics in patients with chronic kidney disease (CKD) using an integrated mobile application and hospital information system (HIS) clinical data. The main goals of this study are: 1. To observe patient self-management recording performance and adherence (continuity of recording blood pressure, blood glucose, medication, and diet). 2. To explore associations between integrated self-management data and disease progression or acute exacerbations (e.g., acute kidney injury, hyperkalemia). 3. To gather foundational evidence for optimizing and improving future digital health applications for CKD management. Participants will be recruited from outpatient clinics at Chungnam National University Hospital and followed prospectively for 1 year with regular follow-up visits.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Adult patients aged 19 years or older and under 85 years. 2. Patients visiting the hospital for chronic kidney disease (CKD) management. 3. Patients diagnosed with CKD or identified as high-risk for CKD requiring continuous management (e.g., diabetes mellitus, hypertension, proteinuria, or decreased eGFR). 4. Patients capable of recording self-management data (blood pressure, diet, medication) independently or with assistance through the provided mobile application. 5. Patients whose clinical data can be collected from the Hospital Information System (HIS). Exclusion Criteria: 1. Patients who do not sign the informed consent form or lack the capacity to fully understand the study protocol and express voluntary consent. 2. Patients currently undergoing maintenance dialysis (hemodialysis or peritoneal dialysis) for end-stage kidney disease (ESKD). 3. Patients deemed unsuitable for participation in the study by the investigator.
💊

What it tests

  • CKD Self-Management Mobile Application
📍

Where

1 site
Chungnam National University Hospital
Daejeon, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy